A new study from the Icahn School of Medicine at Mount Sinai helps explain why some people with multiple myeloma, a type of ...

Support for first and only high-risk smouldering multiple myeloma treatment came from positive phase 3 trial results ...

For the first time in more than a decade, a new frontline treatment for an incurable blood cancer is being added to the ...

Treatment for a rare blood cancer that can cost patients up to almost half a million dollars will be covered by the PBS, in a ...

A British couple who retired to Nicaragua were shocked to be denied cancer treatment on the NHS, after the former army ...

Johnson & Johnson and Legend Biotech are said to have withdrawn an abstract originally planned for next month’s Amer | “At this point, the abstract was withdrawn in alignment with the authors, and we ...

A new study from the Icahn School of Medicine at Mount Sinai helps explain why some people with multiple myeloma, a type of blood cancer, stay in ...

During a live event, Thomas G. Martin, MD, discussed updated findings from the CARTITUDE-1 trial of cilta-cel and what they signify for patients with no disease progression at 5 years.

Australians living with cancer and chronic conditions will now have access to life-changing medicine thanks to a new listing on the Pharmaceutical ...

He was known to millions of Aussies as the face of the AFL's TV coverage. Then Sandy Roberts's life was turned upside down by ...

The benchmark Russell 2000® Growth Index was up 12.19% for the quarter. Trailing the benchmark, the Wasatch Ultra Growth Fund ...